Watson Rebecca’s Gilead Sciences GILD Stock Holding History

Watson Rebecca’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,521	Closed	-$194K	–	190
2020 Q2	$194K	Buy	+2,521	New	+$193K	0.12%	75

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Watson Rebecca's GILD Position: Q3 2020 in Review

Watson Rebecca sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,521 shares — an estimated $194K sold.

Watson Rebecca first reported a position in GILD in Q2 2020 and held it in 1 quarter. The position peaked at $194K in Q2 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Watson Rebecca reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 2,521 Gilead Sciences shares in Q3 2020, an estimated $194K.
Watson Rebecca first reported a position in Gilead Sciences in Q2 2020 and held it in 1 quarter.
Watson Rebecca's Gilead Sciences position peaked at $194K in Q2 2020.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.